OTC Markets OTCQX - Delayed Quote USD
BioLargo, Inc. (BLGO)
0.2200
-0.0025
(-1.12%)
At close: May 2 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
17,779
17,779
--
5,884
2,531
Cost of Revenue
9,926
9,926
--
3,027
1,428
Gross Profit
7,853
7,853
--
2,857
1,103
Operating Expense
12,158
12,158
--
7,913
7,464
Operating Income
-4,305
-4,305
--
-5,056
-6,361
Net Non Operating Interest Income Expense
-139
-139
--
-53
-234
Other Income Expense
97
97
--
-23
-299
Pretax Income
-4,347
-4,347
--
-5,132
-6,894
Net Income Common Stockholders
-2,402
-2,402
--
-4,473
-7,080
Diluted NI Available to Com Stockholders
-2,402
-2,402
--
-4,473
-7,080
Basic EPS
-0.01
-0.01
-0.01
-0.02
-0.03
Diluted EPS
-0.01
-0.01
-0.01
-0.02
-0.03
Basic Average Shares
295,355.0340
298,122.2390
285,956.8520
268,302.2340
247,203.6250
Diluted Average Shares
295,355.0340
298,122.2390
285,956.8520
268,302.2340
247,203.6250
Total Operating Income as Reported
-4,331
-4,331
--
-5,390
-6,778
Total Expenses
22,084
22,084
--
10,940
8,892
Net Income from Continuing & Discontinued Operation
-2,402
-2,402
--
-4,473
-7,080
Normalized Income
-2,499
-2,499
--
-4,450
-6,781
Interest Expense
33
33
--
53
234
Net Interest Income
-139
-139
--
-53
-234
EBIT
-4,314
-4,314
--
-5,079
-6,660
EBITDA
-4,059
-4,059
--
-5,034
-6,640
Reconciled Cost of Revenue
9,926
9,926
--
3,027
1,428
Reconciled Depreciation
255
255
--
45
20
Net Income from Continuing Operation Net Minority Interest
-2,402
-2,402
--
-4,473
-7,080
Total Unusual Items Excluding Goodwill
97
97
--
-23
-299
Total Unusual Items
97
97
--
-23
-299
Normalized EBITDA
-4,156
-4,156
--
-5,011
-6,341
12/31/2021 - 3/22/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade